Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:20 PM
Ignite Modification Date: 2025-12-25 @ 7:07 PM
NCT ID: NCT01055704
Description: None
Frequency Threshold: 5
Time Frame: 10 days
Study: NCT01055704
Study Brief: Effect of Methylnaltrexone on GI Transit in Healthy Volunteers
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Methylnaltrexone 0.30 mg/kg None None None 0 16 12 16 View
Codeine 30 mg None None None 0 8 7 8 View
Methylnaltrexone 0.30 mg/kg + Codeine 30 mg None None None 0 16 11 16 View
Placebo None None None 0 8 5 8 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Burn or sting with injection SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (Unspecified) View
Fatigue SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Flatulence SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Headache SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Sleepiness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Emesis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Musculoskeletal pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
Abdominal bloating SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View